nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxsalen—CYP2A6—Ifosfamide—testicular cancer	0.419	0.606	CbGbCtD
Methoxsalen—CYP3A4—Ifosfamide—testicular cancer	0.0838	0.121	CbGbCtD
Methoxsalen—CYP1A2—Etoposide—testicular cancer	0.0764	0.111	CbGbCtD
Methoxsalen—CYP3A4—Vinblastine—testicular cancer	0.0444	0.0643	CbGbCtD
Methoxsalen—CYP3A4—Etoposide—testicular cancer	0.04	0.0579	CbGbCtD
Methoxsalen—CYP3A4—Doxorubicin—testicular cancer	0.0273	0.0395	CbGbCtD
Methoxsalen—Pain of skin—Bleomycin—testicular cancer	0.0176	0.057	CcSEcCtD
Methoxsalen—Digestion impaired—Chlorambucil—testicular cancer	0.00802	0.026	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Bleomycin—testicular cancer	0.00698	0.0226	CcSEcCtD
Methoxsalen—Folliculitis—Dactinomycin—testicular cancer	0.00616	0.0199	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Ifosfamide—testicular cancer	0.00597	0.0193	CcSEcCtD
Methoxsalen—Sunburn—Methotrexate—testicular cancer	0.00556	0.018	CcSEcCtD
Methoxsalen—Tenderness—Bleomycin—testicular cancer	0.00476	0.0154	CcSEcCtD
Methoxsalen—Tenderness—Ifosfamide—testicular cancer	0.00407	0.0132	CcSEcCtD
Methoxsalen—Skin exfoliation—Bleomycin—testicular cancer	0.00396	0.0128	CcSEcCtD
Methoxsalen—Leukoderma—Methotrexate—testicular cancer	0.00395	0.0128	CcSEcCtD
Methoxsalen—Infection—Carboplatin—testicular cancer	0.0037	0.012	CcSEcCtD
Methoxsalen—Leukoderma—Epirubicin—testicular cancer	0.0037	0.012	CcSEcCtD
Methoxsalen—Inflammation—Ifosfamide—testicular cancer	0.00366	0.0118	CcSEcCtD
Methoxsalen—Tenderness—Cisplatin—testicular cancer	0.00351	0.0113	CcSEcCtD
Methoxsalen—Leukoderma—Doxorubicin—testicular cancer	0.00342	0.0111	CcSEcCtD
Methoxsalen—Skin exfoliation—Ifosfamide—testicular cancer	0.00339	0.011	CcSEcCtD
Methoxsalen—Body temperature increased—Carboplatin—testicular cancer	0.00294	0.00952	CcSEcCtD
Methoxsalen—Skin exfoliation—Cisplatin—testicular cancer	0.00292	0.00945	CcSEcCtD
Methoxsalen—Inflammation—Etoposide—testicular cancer	0.00289	0.00935	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Methotrexate—testicular cancer	0.00282	0.00913	CcSEcCtD
Methoxsalen—Depression—Vinblastine—testicular cancer	0.00274	0.00887	CcSEcCtD
Methoxsalen—Skin exfoliation—Etoposide—testicular cancer	0.00268	0.00866	CcSEcCtD
Methoxsalen—Folliculitis—Methotrexate—testicular cancer	0.00267	0.00864	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Epirubicin—testicular cancer	0.00264	0.00855	CcSEcCtD
Methoxsalen—Folliculitis—Epirubicin—testicular cancer	0.0025	0.00809	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Doxorubicin—testicular cancer	0.00244	0.00791	CcSEcCtD
Methoxsalen—Redness—Epirubicin—testicular cancer	0.00233	0.00753	CcSEcCtD
Methoxsalen—Folliculitis—Doxorubicin—testicular cancer	0.00231	0.00748	CcSEcCtD
Methoxsalen—Blister—Epirubicin—testicular cancer	0.00218	0.00705	CcSEcCtD
Methoxsalen—Redness—Doxorubicin—testicular cancer	0.00215	0.00697	CcSEcCtD
Methoxsalen—Blister—Doxorubicin—testicular cancer	0.00202	0.00653	CcSEcCtD
Methoxsalen—Ill-defined disorder—Vinblastine—testicular cancer	0.00199	0.00645	CcSEcCtD
Methoxsalen—Malaise—Vinblastine—testicular cancer	0.00194	0.00627	CcSEcCtD
Methoxsalen—Vertigo—Vinblastine—testicular cancer	0.00193	0.00625	CcSEcCtD
Methoxsalen—Infection—Chlorambucil—testicular cancer	0.0019	0.00615	CcSEcCtD
Methoxsalen—Herpes simplex—Methotrexate—testicular cancer	0.00182	0.0059	CcSEcCtD
Methoxsalen—Erythema—Bleomycin—testicular cancer	0.00181	0.00587	CcSEcCtD
Methoxsalen—Discomfort—Vinblastine—testicular cancer	0.00181	0.00585	CcSEcCtD
Methoxsalen—Inflammation—Methotrexate—testicular cancer	0.00173	0.0056	CcSEcCtD
Methoxsalen—Herpes simplex—Epirubicin—testicular cancer	0.0017	0.00552	CcSEcCtD
Methoxsalen—Erythema—Dactinomycin—testicular cancer	0.00169	0.00548	CcSEcCtD
Methoxsalen—Dyspepsia—Chlorambucil—testicular cancer	0.00168	0.00545	CcSEcCtD
Methoxsalen—Ill-defined disorder—Bleomycin—testicular cancer	0.00168	0.00545	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00165	0.00535	CcSEcCtD
Methoxsalen—Malaise—Bleomycin—testicular cancer	0.00164	0.0053	CcSEcCtD
Methoxsalen—Inflammation—Epirubicin—testicular cancer	0.00162	0.00524	CcSEcCtD
Methoxsalen—Skin exfoliation—Methotrexate—testicular cancer	0.0016	0.00519	CcSEcCtD
Methoxsalen—Arrhythmia—Ifosfamide—testicular cancer	0.00159	0.00515	CcSEcCtD
Methoxsalen—Herpes simplex—Doxorubicin—testicular cancer	0.00158	0.0051	CcSEcCtD
Methoxsalen—Feeling abnormal—Chlorambucil—testicular cancer	0.00158	0.0051	CcSEcCtD
Methoxsalen—Ill-defined disorder—Dactinomycin—testicular cancer	0.00157	0.00508	CcSEcCtD
Methoxsalen—Erythema—Ifosfamide—testicular cancer	0.00155	0.00502	CcSEcCtD
Methoxsalen—Discomfort—Bleomycin—testicular cancer	0.00153	0.00494	CcSEcCtD
Methoxsalen—Malaise—Dactinomycin—testicular cancer	0.00153	0.00494	CcSEcCtD
Methoxsalen—Urticaria—Chlorambucil—testicular cancer	0.00152	0.00492	CcSEcCtD
Methoxsalen—Body temperature increased—Chlorambucil—testicular cancer	0.00151	0.0049	CcSEcCtD
Methoxsalen—Skin exfoliation—Epirubicin—testicular cancer	0.0015	0.00485	CcSEcCtD
Methoxsalen—Inflammation—Doxorubicin—testicular cancer	0.0015	0.00485	CcSEcCtD
Methoxsalen—Oedema—Bleomycin—testicular cancer	0.00148	0.00479	CcSEcCtD
Methoxsalen—Infection—Bleomycin—testicular cancer	0.00147	0.00476	CcSEcCtD
Methoxsalen—Feeling abnormal—Vinblastine—testicular cancer	0.00145	0.00468	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Epirubicin—testicular cancer	0.00144	0.00467	CcSEcCtD
Methoxsalen—Ill-defined disorder—Ifosfamide—testicular cancer	0.00144	0.00466	CcSEcCtD
Methoxsalen—Discomfort—Dactinomycin—testicular cancer	0.00142	0.00461	CcSEcCtD
Methoxsalen—Hypersensitivity—Chlorambucil—testicular cancer	0.00141	0.00456	CcSEcCtD
Methoxsalen—Malaise—Ifosfamide—testicular cancer	0.0014	0.00453	CcSEcCtD
Methoxsalen—Vertigo—Ifosfamide—testicular cancer	0.00139	0.00451	CcSEcCtD
Methoxsalen—Skin exfoliation—Doxorubicin—testicular cancer	0.00139	0.00449	CcSEcCtD
Methoxsalen—Hypotension—Bleomycin—testicular cancer	0.00138	0.00448	CcSEcCtD
Methoxsalen—Oedema—Dactinomycin—testicular cancer	0.00138	0.00447	CcSEcCtD
Methoxsalen—Infection—Dactinomycin—testicular cancer	0.00137	0.00444	CcSEcCtD
Methoxsalen—Arrhythmia—Cisplatin—testicular cancer	0.00137	0.00444	CcSEcCtD
Methoxsalen—Pruritus—Chlorambucil—testicular cancer	0.00135	0.00438	CcSEcCtD
Methoxsalen—Erythema—Cisplatin—testicular cancer	0.00134	0.00433	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Doxorubicin—testicular cancer	0.00134	0.00432	CcSEcCtD
Methoxsalen—Discomfort—Ifosfamide—testicular cancer	0.0013	0.00422	CcSEcCtD
Methoxsalen—Hypersensitivity—Vinblastine—testicular cancer	0.00129	0.00418	CcSEcCtD
Methoxsalen—Muscle spasms—Cisplatin—testicular cancer	0.00129	0.00416	CcSEcCtD
Methoxsalen—Oedema—Ifosfamide—testicular cancer	0.00127	0.0041	CcSEcCtD
Methoxsalen—Infection—Ifosfamide—testicular cancer	0.00126	0.00407	CcSEcCtD
Methoxsalen—Ill-defined disorder—Cisplatin—testicular cancer	0.00124	0.00402	CcSEcCtD
Methoxsalen—Skin disorder—Ifosfamide—testicular cancer	0.00123	0.00398	CcSEcCtD
Methoxsalen—Feeling abnormal—Bleomycin—testicular cancer	0.00122	0.00395	CcSEcCtD
Methoxsalen—Malaise—Cisplatin—testicular cancer	0.00121	0.0039	CcSEcCtD
Methoxsalen—Dysgeusia—Etoposide—testicular cancer	0.0012	0.00388	CcSEcCtD
Methoxsalen—Dermatitis bullous—Epirubicin—testicular cancer	0.00119	0.00386	CcSEcCtD
Methoxsalen—Hypotension—Ifosfamide—testicular cancer	0.00118	0.00383	CcSEcCtD
Methoxsalen—Muscle spasms—Etoposide—testicular cancer	0.00118	0.00381	CcSEcCtD
Methoxsalen—Urticaria—Bleomycin—testicular cancer	0.00118	0.00381	CcSEcCtD
Methoxsalen—Body temperature increased—Bleomycin—testicular cancer	0.00117	0.00379	CcSEcCtD
Methoxsalen—Dizziness—Vinblastine—testicular cancer	0.00116	0.00375	CcSEcCtD
Methoxsalen—Feeling abnormal—Dactinomycin—testicular cancer	0.00114	0.00368	CcSEcCtD
Methoxsalen—Nausea—Chlorambucil—testicular cancer	0.00114	0.00368	CcSEcCtD
Methoxsalen—Ill-defined disorder—Etoposide—testicular cancer	0.00114	0.00368	CcSEcCtD
Methoxsalen—Discomfort—Cisplatin—testicular cancer	0.00112	0.00364	CcSEcCtD
Methoxsalen—Malaise—Etoposide—testicular cancer	0.0011	0.00358	CcSEcCtD
Methoxsalen—Dermatitis bullous—Doxorubicin—testicular cancer	0.0011	0.00357	CcSEcCtD
Methoxsalen—Vertigo—Etoposide—testicular cancer	0.0011	0.00356	CcSEcCtD
Methoxsalen—Headache—Vinblastine—testicular cancer	0.0011	0.00356	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00109	0.00354	CcSEcCtD
Methoxsalen—Body temperature increased—Dactinomycin—testicular cancer	0.00109	0.00353	CcSEcCtD
Methoxsalen—Oedema—Cisplatin—testicular cancer	0.00109	0.00353	CcSEcCtD
Methoxsalen—Hypersensitivity—Bleomycin—testicular cancer	0.00109	0.00353	CcSEcCtD
Methoxsalen—Infection—Cisplatin—testicular cancer	0.00108	0.00351	CcSEcCtD
Methoxsalen—Skin disorder—Cisplatin—testicular cancer	0.00106	0.00343	CcSEcCtD
Methoxsalen—Pruritus—Bleomycin—testicular cancer	0.00105	0.00339	CcSEcCtD
Methoxsalen—Dry skin—Epirubicin—testicular cancer	0.00105	0.00338	CcSEcCtD
Methoxsalen—Feeling abnormal—Ifosfamide—testicular cancer	0.00104	0.00338	CcSEcCtD
Methoxsalen—Nausea—Vinblastine—testicular cancer	0.00104	0.00337	CcSEcCtD
Methoxsalen—Discomfort—Etoposide—testicular cancer	0.00103	0.00334	CcSEcCtD
Methoxsalen—Hypotension—Cisplatin—testicular cancer	0.00102	0.0033	CcSEcCtD
Methoxsalen—Hypersensitivity—Dactinomycin—testicular cancer	0.00102	0.00329	CcSEcCtD
Methoxsalen—Urticaria—Ifosfamide—testicular cancer	0.00101	0.00325	CcSEcCtD
Methoxsalen—Body temperature increased—Ifosfamide—testicular cancer	0.001	0.00324	CcSEcCtD
Methoxsalen—Infection—Etoposide—testicular cancer	0.000993	0.00321	CcSEcCtD
Methoxsalen—Skin disorder—Etoposide—testicular cancer	0.000971	0.00314	CcSEcCtD
Methoxsalen—Dry skin—Doxorubicin—testicular cancer	0.000967	0.00313	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Methotrexate—testicular cancer	0.000961	0.00311	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000942	0.00305	CcSEcCtD
Methoxsalen—Depression—Methotrexate—testicular cancer	0.000936	0.00303	CcSEcCtD
Methoxsalen—Hypotension—Etoposide—testicular cancer	0.000934	0.00302	CcSEcCtD
Methoxsalen—Rash—Bleomycin—testicular cancer	0.000934	0.00302	CcSEcCtD
Methoxsalen—Dermatitis—Bleomycin—testicular cancer	0.000933	0.00302	CcSEcCtD
Methoxsalen—Hypersensitivity—Ifosfamide—testicular cancer	0.000933	0.00302	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Epirubicin—testicular cancer	0.0009	0.00291	CcSEcCtD
Methoxsalen—Feeling abnormal—Cisplatin—testicular cancer	0.000899	0.00291	CcSEcCtD
Methoxsalen—Pruritus—Ifosfamide—testicular cancer	0.000896	0.0029	CcSEcCtD
Methoxsalen—Nausea—Bleomycin—testicular cancer	0.00088	0.00285	CcSEcCtD
Methoxsalen—Rash—Dactinomycin—testicular cancer	0.000871	0.00282	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Etoposide—testicular cancer	0.000863	0.00279	CcSEcCtD
Methoxsalen—Body temperature increased—Cisplatin—testicular cancer	0.000863	0.00279	CcSEcCtD
Methoxsalen—Dizziness—Ifosfamide—testicular cancer	0.000837	0.00271	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000832	0.00269	CcSEcCtD
Methoxsalen—Feeling abnormal—Etoposide—testicular cancer	0.000824	0.00267	CcSEcCtD
Methoxsalen—Nausea—Dactinomycin—testicular cancer	0.000821	0.00266	CcSEcCtD
Methoxsalen—Hypersensitivity—Cisplatin—testicular cancer	0.000804	0.0026	CcSEcCtD
Methoxsalen—Rash—Ifosfamide—testicular cancer	0.000798	0.00258	CcSEcCtD
Methoxsalen—Dermatitis—Ifosfamide—testicular cancer	0.000797	0.00258	CcSEcCtD
Methoxsalen—Urticaria—Etoposide—testicular cancer	0.000794	0.00257	CcSEcCtD
Methoxsalen—Body temperature increased—Etoposide—testicular cancer	0.00079	0.00256	CcSEcCtD
Methoxsalen—Nausea—Ifosfamide—testicular cancer	0.000752	0.00243	CcSEcCtD
Methoxsalen—Hypersensitivity—Etoposide—testicular cancer	0.000737	0.00238	CcSEcCtD
Methoxsalen—Erythema—Methotrexate—testicular cancer	0.000734	0.00237	CcSEcCtD
Methoxsalen—Dysgeusia—Methotrexate—testicular cancer	0.000719	0.00233	CcSEcCtD
Methoxsalen—Pruritus—Etoposide—testicular cancer	0.000707	0.00229	CcSEcCtD
Methoxsalen—Arrhythmia—Epirubicin—testicular cancer	0.000705	0.00228	CcSEcCtD
Methoxsalen—Rash—Cisplatin—testicular cancer	0.000688	0.00223	CcSEcCtD
Methoxsalen—Dermatitis—Cisplatin—testicular cancer	0.000688	0.00223	CcSEcCtD
Methoxsalen—Erythema—Epirubicin—testicular cancer	0.000687	0.00222	CcSEcCtD
Methoxsalen—Ill-defined disorder—Methotrexate—testicular cancer	0.000681	0.0022	CcSEcCtD
Methoxsalen—Tension—Epirubicin—testicular cancer	0.000674	0.00218	CcSEcCtD
Methoxsalen—Dysgeusia—Epirubicin—testicular cancer	0.000673	0.00218	CcSEcCtD
Methoxsalen—Nervousness—Epirubicin—testicular cancer	0.000667	0.00216	CcSEcCtD
Methoxsalen—Malaise—Methotrexate—testicular cancer	0.000662	0.00214	CcSEcCtD
Methoxsalen—Dizziness—Etoposide—testicular cancer	0.000661	0.00214	CcSEcCtD
Methoxsalen—Muscle spasms—Epirubicin—testicular cancer	0.00066	0.00214	CcSEcCtD
Methoxsalen—Vertigo—Methotrexate—testicular cancer	0.000659	0.00213	CcSEcCtD
Methoxsalen—Arrhythmia—Doxorubicin—testicular cancer	0.000652	0.00211	CcSEcCtD
Methoxsalen—Nausea—Cisplatin—testicular cancer	0.000648	0.0021	CcSEcCtD
Methoxsalen—Ill-defined disorder—Epirubicin—testicular cancer	0.000637	0.00206	CcSEcCtD
Methoxsalen—Erythema—Doxorubicin—testicular cancer	0.000635	0.00206	CcSEcCtD
Methoxsalen—Rash—Etoposide—testicular cancer	0.00063	0.00204	CcSEcCtD
Methoxsalen—Dermatitis—Etoposide—testicular cancer	0.00063	0.00204	CcSEcCtD
Methoxsalen—Headache—Etoposide—testicular cancer	0.000626	0.00203	CcSEcCtD
Methoxsalen—Tension—Doxorubicin—testicular cancer	0.000624	0.00202	CcSEcCtD
Methoxsalen—Dysgeusia—Doxorubicin—testicular cancer	0.000622	0.00201	CcSEcCtD
Methoxsalen—Malaise—Epirubicin—testicular cancer	0.000619	0.002	CcSEcCtD
Methoxsalen—Discomfort—Methotrexate—testicular cancer	0.000617	0.002	CcSEcCtD
Methoxsalen—Nervousness—Doxorubicin—testicular cancer	0.000617	0.002	CcSEcCtD
Methoxsalen—Vertigo—Epirubicin—testicular cancer	0.000617	0.002	CcSEcCtD
Methoxsalen—Muscle spasms—Doxorubicin—testicular cancer	0.000611	0.00198	CcSEcCtD
Methoxsalen—Infection—Methotrexate—testicular cancer	0.000595	0.00193	CcSEcCtD
Methoxsalen—Nausea—Etoposide—testicular cancer	0.000594	0.00192	CcSEcCtD
Methoxsalen—Ill-defined disorder—Doxorubicin—testicular cancer	0.00059	0.00191	CcSEcCtD
Methoxsalen—Skin disorder—Methotrexate—testicular cancer	0.000582	0.00188	CcSEcCtD
Methoxsalen—Discomfort—Epirubicin—testicular cancer	0.000578	0.00187	CcSEcCtD
Methoxsalen—Malaise—Doxorubicin—testicular cancer	0.000573	0.00185	CcSEcCtD
Methoxsalen—Vertigo—Doxorubicin—testicular cancer	0.000571	0.00185	CcSEcCtD
Methoxsalen—Oedema—Epirubicin—testicular cancer	0.00056	0.00181	CcSEcCtD
Methoxsalen—Hypotension—Methotrexate—testicular cancer	0.00056	0.00181	CcSEcCtD
Methoxsalen—Infection—Epirubicin—testicular cancer	0.000557	0.0018	CcSEcCtD
Methoxsalen—Skin disorder—Epirubicin—testicular cancer	0.000544	0.00176	CcSEcCtD
Methoxsalen—Insomnia—Methotrexate—testicular cancer	0.000542	0.00175	CcSEcCtD
Methoxsalen—Discomfort—Doxorubicin—testicular cancer	0.000534	0.00173	CcSEcCtD
Methoxsalen—Dyspepsia—Methotrexate—testicular cancer	0.000527	0.00171	CcSEcCtD
Methoxsalen—Hypotension—Epirubicin—testicular cancer	0.000524	0.00169	CcSEcCtD
Methoxsalen—Oedema—Doxorubicin—testicular cancer	0.000519	0.00168	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000517	0.00167	CcSEcCtD
Methoxsalen—Infection—Doxorubicin—testicular cancer	0.000515	0.00167	CcSEcCtD
Methoxsalen—Insomnia—Epirubicin—testicular cancer	0.000507	0.00164	CcSEcCtD
Methoxsalen—Skin disorder—Doxorubicin—testicular cancer	0.000504	0.00163	CcSEcCtD
Methoxsalen—Feeling abnormal—Methotrexate—testicular cancer	0.000494	0.0016	CcSEcCtD
Methoxsalen—Dyspepsia—Epirubicin—testicular cancer	0.000493	0.0016	CcSEcCtD
Methoxsalen—Hypotension—Doxorubicin—testicular cancer	0.000485	0.00157	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000484	0.00157	CcSEcCtD
Methoxsalen—Urticaria—Methotrexate—testicular cancer	0.000476	0.00154	CcSEcCtD
Methoxsalen—Body temperature increased—Methotrexate—testicular cancer	0.000473	0.00153	CcSEcCtD
Methoxsalen—Insomnia—Doxorubicin—testicular cancer	0.000469	0.00152	CcSEcCtD
Methoxsalen—Feeling abnormal—Epirubicin—testicular cancer	0.000462	0.00149	CcSEcCtD
Methoxsalen—Dyspepsia—Doxorubicin—testicular cancer	0.000456	0.00148	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000448	0.00145	CcSEcCtD
Methoxsalen—Urticaria—Epirubicin—testicular cancer	0.000445	0.00144	CcSEcCtD
Methoxsalen—Body temperature increased—Epirubicin—testicular cancer	0.000443	0.00143	CcSEcCtD
Methoxsalen—Hypersensitivity—Methotrexate—testicular cancer	0.000441	0.00143	CcSEcCtD
Methoxsalen—Feeling abnormal—Doxorubicin—testicular cancer	0.000427	0.00138	CcSEcCtD
Methoxsalen—Pruritus—Methotrexate—testicular cancer	0.000424	0.00137	CcSEcCtD
Methoxsalen—Hypersensitivity—Epirubicin—testicular cancer	0.000413	0.00134	CcSEcCtD
Methoxsalen—Urticaria—Doxorubicin—testicular cancer	0.000412	0.00133	CcSEcCtD
Methoxsalen—Body temperature increased—Doxorubicin—testicular cancer	0.00041	0.00133	CcSEcCtD
Methoxsalen—Pruritus—Epirubicin—testicular cancer	0.000397	0.00128	CcSEcCtD
Methoxsalen—Dizziness—Methotrexate—testicular cancer	0.000396	0.00128	CcSEcCtD
Methoxsalen—Hypersensitivity—Doxorubicin—testicular cancer	0.000382	0.00124	CcSEcCtD
Methoxsalen—Rash—Methotrexate—testicular cancer	0.000378	0.00122	CcSEcCtD
Methoxsalen—Dermatitis—Methotrexate—testicular cancer	0.000377	0.00122	CcSEcCtD
Methoxsalen—Headache—Methotrexate—testicular cancer	0.000375	0.00121	CcSEcCtD
Methoxsalen—Dizziness—Epirubicin—testicular cancer	0.000371	0.0012	CcSEcCtD
Methoxsalen—Pruritus—Doxorubicin—testicular cancer	0.000367	0.00119	CcSEcCtD
Methoxsalen—Nausea—Methotrexate—testicular cancer	0.000356	0.00115	CcSEcCtD
Methoxsalen—Rash—Epirubicin—testicular cancer	0.000353	0.00114	CcSEcCtD
Methoxsalen—Dermatitis—Epirubicin—testicular cancer	0.000353	0.00114	CcSEcCtD
Methoxsalen—Headache—Epirubicin—testicular cancer	0.000351	0.00114	CcSEcCtD
Methoxsalen—Dizziness—Doxorubicin—testicular cancer	0.000343	0.00111	CcSEcCtD
Methoxsalen—Nausea—Epirubicin—testicular cancer	0.000333	0.00108	CcSEcCtD
Methoxsalen—Rash—Doxorubicin—testicular cancer	0.000327	0.00106	CcSEcCtD
Methoxsalen—Dermatitis—Doxorubicin—testicular cancer	0.000327	0.00106	CcSEcCtD
Methoxsalen—Headache—Doxorubicin—testicular cancer	0.000325	0.00105	CcSEcCtD
Methoxsalen—Nausea—Doxorubicin—testicular cancer	0.000308	0.000997	CcSEcCtD
